FGF19 and metabolic dysfunction-associated steatotic liver disease: In children with NAFLD, gene expression of β-Klotho [20], a hepatic coreceptor for FGF19, and FXR protein abundance [19] are decreased in liver tissue, and their levels are inversely correlated with disease severity.